Does amniotic fluid alpha-fetoprotein have diagnostic or prognostic value at the time of second midtrimester genetic amniocentesis?

Fetal Diagnosis and Therapy

Volumn 17, Issue 3, 2002, Pages 147-152

  Mandruzzato, G P ^a   Fischer Tamaro, L ^a   De Seta, F ^a   D'Ottavio, G ^a   Rustico, M A ^a   Conoscenti, G ^a   Meir, Y L ^a   Pinzano, R ^a   Maso, G ^a   Grasso, A ^a   Gigli, C ^a  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

Fetoprotein; Amniocentesis; Amniotic fluid; Chromosomes; Malformations; Ultrasound

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AMNIOCENTESIS; AMNION FLUID ANALYSIS; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ECHOGRAPHY; FEMALE; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; PREGNANCY TERMINATION; PRIORITY JOURNAL; PROGNOSIS; SECOND TRIMESTER PREGNANCY;

ABNORMALITIES; ABORTION, SPONTANEOUS; ALPHA-FETOPROTEINS; AMNIOCENTESIS; AMNIOTIC FLUID; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 18; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; PREGNANCY; RETROSPECTIVE STUDIES; TRISOMY;

EID: 18344368644     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048028     Document Type: Article

References (23)

1. Alphafetoprotein levels in amniotic fluid from 8 to 18 weeks of pregnancy
2. Interpreting elevated amniotic fluid alpha-fetoprotein levels in clinical practice: Use of predictive value positive concept
3. Routine amniotic fluid α-fetoprotein measurement in 34,000 pregnancies
4. Evaluation of the lemon and banana signs in one hundred thirty fetuses with open spina bifida
5. Are routine alpha-fetoprotein and acetylcholinesterase determinations still necessary at second-trimester amniocentesis? Impact of high-resolution ultrasonography
6. Amniotic fluid alpha-fetoprotein determination at the time of genetic amniocentesis: Has it outlived usefulness?
7. Absence of need for amniocentesis in patients with elevated levels of maternal serum alpha-fetoprotein and normal ultrasonographic examinations
8. The role of ultrasonography and amniocentesis in the evaluation of pregnancies at risk of neural tube defects
9. The California maternal serum α-fetoprotein screening program: The role of ultrasonography in the detection of spina bifida
10. Congenital nephrosis as a cause of elevated alpha-fetoprotein
11. Congenital nephrosis in low-risk pregnancies
12. The snowflake sign. A sonographic marker for prenatal detection of fetal skin denudation
13. Aplasia cutis congenita associated with epidermolysis bullosa and pyloric atersia: The diagnostic role of prenatal ultrasonography
14. Amniotic fluid AFP levels and Down syndrome
15. Risk of fetal chromosomal anomalies in patients with elevated maternal serum alpha-fetoprotein
16. Amniotic fluid alpha-fetoprotein levels and pregnancy outcome
17. Decreased levels of amniotic fluid alpha-fetoprotein associated with Down syndrome
18. A comparison of amniotic fluid alpha-fetoprotein and acetylchlinesterase in the prenatal diagnosis of open neural tube defects and anterior abdominal wall defects
19. Amniotic fluid alpha-fetoprotein levels and the prenatal diagnosis of neural tube defects: A collaborative study of 2180 pregnancies in the Netherlands
20. Routine amniotic fluid alpha-feteprotein assay: Experience with 40,000 pregnancies
21. Congenital nephrosis: Detection of index cases through maternal serum α-fetoprotein screening
22. Prenatal diagnosis of epidermolysis bullosa letalis
23. Alpha-fetoprotein content of amniotic fluid in normal and abnormal pregnancies